Urilux/E+ via Getty Images Investment Overview Amgen Inc. (NASDAQ:AMGN), the Thousand Oaks, California based Pharma giant, reported its Q2 2024 earnings this Tuesday, August 6th. The last time I covered Amgen for Seeking Alpha was in May this year, following Q1 earnings. I gave Amgen stock a “buy” rating, when shares traded at $311, and they subsequently reached a high of $335 — up ~8%, before dipping after Q2 results were announced. First, let's consider the headline figures. Revenues grew by an impres ...